6796 — Medimaging Integrated Solution Share Price
- TWD2.90bn
- TWD2.83bn
- TWD537.15m
- 51
- 15
- 26
- 17
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 3.99 | ||
Price to Tang. Book | 4.13 | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 5.9 | ||
EV to EBITDA | 40.7 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 2.27% | ||
Return on Equity | 3.63% | ||
Operating Margin | 5.16% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | TWDm | 314.5 | 402.47 | 485.87 | 502.09 | 537.15 | n/a | n/a | 7.87% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | -91.74 | +1018.18 | +23.61 | -4.26 | +1.56 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Medimaging Integrated Solution Inc is a Taiwan-based company mainly engaged in the research and development, manufacture and marketing of medical imaging and diagnosis related products. The Company develops advanced intelligent medical equipment and provides medical solutions. The main products are non-mydriatic fundus cameras and Hand-held digital five sense mirror. The Company distributes its products to Europe, the United States, mainland China and other countries Asia. The Company develops the original equipment manufacturing (OEM) business is carried out through the brand horus SCOPE and ODM.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- August 5th, 2010
- Public Since
- April 16th, 2021
- No. of Shareholders
- 3,621
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Taiwan Stock Exchange
- Shares in Issue
- 34,750,155
- Address
- 3F, No.24-2, Industry East Road IV, HSINCHU, 300
- Web
- https://www.miis.com.tw/index.php?lang=us
- Phone
- +886 35798860
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for 6796
Similar to 6796
Apex Biotechnology
Taiwan Stock Exchange
Wellell
Taiwan Stock Exchange
Bionime
Taiwan Stock Exchange
CHC Healthcare
Taiwan Stock Exchange
Excelsior Medical Co
Taiwan Stock Exchange
FAQ
As of Today at 22:03 UTC, shares in Medimaging Integrated Solution are trading at TWD83.50. This share price information is delayed by 15 minutes.
Shares in Medimaging Integrated Solution last closed at TWD83.50 and the price had moved by -23.74% over the past 365 days. In terms of relative price strength the Medimaging Integrated Solution share price has underperformed the FTSE Developed Asia Pacific Index by -29.33% over the past year.
There is no consensus recommendation for this security.
Find out moreThe Medimaging Integrated Solution dividend yield is 2.15% based on the trailing twelve month period.
Last year, Medimaging Integrated Solution paid a total dividend of TWD1.80, and it currently has a trailing dividend yield of 2.15%. We do not have any data on when Medimaging Integrated Solution is to next pay dividends.
We do not have data on when Medimaging Integrated Solution is to next pay dividends. The historic dividend yield on Medimaging Integrated Solution shares is currently 2.15%.
To buy shares in Medimaging Integrated Solution you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of TWD83.50, shares in Medimaging Integrated Solution had a market capitalisation of TWD2.90bn.
Here are the trading details for Medimaging Integrated Solution:
- Country of listing: Taiwan
- Exchange: TAI
- Ticker Symbol: 6796
Based on an overall assessment of its quality, value and momentum Medimaging Integrated Solution is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Medimaging Integrated Solution. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -8.18%.
As of the last closing price of TWD83.50, shares in Medimaging Integrated Solution were trading -10.31% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Medimaging Integrated Solution PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at TWD83.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Medimaging Integrated Solution's directors